In relation to cerebral ischemia, it has been shown that disruption of downstream MyD88-independent (TRIF) TLR pathway does not confer protection in in vitro and in vivo models of cerebral ischemia [3]. The gene discussed is MYD88; the disease is Cerebral ischemia.